Merus N.V.
Merus N.V. (MRUS) Financial Performance & Income Statement Overview
Review Merus N.V. (MRUS) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Merus N.V. (MRUS) Income Statement & Financial Overview
View the income breakdown for Merus N.V. MRUS across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $26.49M | $9.14M | $11.77M | $7.33M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $26.49M | $9.14M | $11.77M | $7.33M |
| Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $1.00 |
| R&D Expenses | $80.12M | $74.43M | $63.24M | $49.12M |
| SG&A Expenses | $22.11M | $23.37M | $20.77M | $21.95M |
| Operating Expenses | $102.23M | $97.79M | $84.004M | $71.07M |
| Total Costs & Expenses | $102.23M | $99.65M | $84.004M | $71.71M |
| Interest Income | $7.20M | $8.49M | $10.25M | $7.13M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $2.07M | $589000.00 | $635000.00 | $640000.00 |
| EBITDA | -$92.55M | -$88.06M | -$96.29M | -$59.50M |
| EBITDA Ratio | -$3.49 | -$9.63 | -$8.18 | -$8.11 |
| Operating Income | -$75.74M | -$88.65M | -$72.23M | -$64.37M |
| Operating Income Ratio | -$2.86 | -$9.70 | -$6.14 | -$8.78 |
| Other Income/Expenses (Net) | -$18.88M | $59.49M | -$24.70M | $12.37M |
| Income Before Tax | -$94.62M | -$29.16M | -$96.93M | -$47.73M |
| Income Before Tax Ratio | -$3.57 | -$3.19 | -$8.23 | -$6.51 |
| Income Tax Expense | $1.85M | $1.76M | $2.98M | $2.32M |
| Net Income | -$96.47M | -$30.92M | -$99.91M | -$50.04M |
| Net Income Ratio | -$3.64 | -$3.38 | -$8.49 | -$6.83 |
| EPS | -$1.40 | -$0.48 | -$1.46 | -$0.81 |
| Diluted EPS | -$1.40 | -$0.48 | -$1.46 | -$0.81 |
| Weighted Avg Shares Outstanding | $69.02M | $68.83M | $68.25M | $61.85M |
| Weighted Avg Shares Outstanding (Diluted) | $69.02M | $68.83M | $68.25M | $61.85M |
Over the past four quarters, Merus N.V. demonstrated steady revenue growth, increasing from $7.33M in Q2 2024 to $26.49M in Q1 2025. Operating income reached -$75.74M in Q1 2025, maintaining a consistent -286% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$92.55M, reflecting operational efficiency. Net income dropped to -$96.47M, with EPS at -$1.40. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan